The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...
In the study, 33.4% of patients taking Wegovy were admitted, compared to about 37% in the placebo cohort. Use of the weight loss drug was also linked to shorter hospital stays. Eli Lilly and Novo ...
Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of ...